Rubrik, Inc. Class A RBRK 深 沪
已收盘 01-09 16:00:00 美东时间
70.56
-1.110
-1.55%
华盛通- 最 高72.49
- 今 开72.20
- 成交量 263.68万股
- 最 低 70.41
- 昨 收 71.67
- 总市值 139.00亿
- 52周最高 103.00
- 市盈率 静 --
- 换手率 1.34%
- 52周最低 47.3503
- 委 比 -68.09%
- 总股本 1.97亿
- 历史最高 103.00
- 量 比 0.91
- 振 幅 2.90%
- 历史最低 28.34
- 每 手 1
- 风险率 10.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
Palantir outperforms bulk of enterprise software stocks during 2025
Despite a banner year for a wide range of semiconductor companies in the tech sector, most enterprise software stocks demonstrated more muted action throughout 2025. The Philadelphia Semiconductor Ind...
01-01 01:10
美股大行评级 | 潜在涨幅1391.05%！Maison Solutions获Ascendiant Capital升目标价至4.5美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持Maison Solutions"买入"评级，目标价从4.25美元升至4.5美元；HC Wainwright & Co.：维持Greenwich LifeSciences"买入"评级，目标价从39美元升至50美元
2025-12-31 10:25
Stephens & Co. Initiates Coverage On Rubrik with Overweight Rating, Announces Price Target of $105
Stephens & Co. analyst Todd Weller initiates coverage on Rubrik (NYSE:RBRK) with a Overweight rating and announces Price Target of $105.
2025-12-30 22:27
Jim Cramer Is Bullish On This Tech Stock: 'Continue To Own It'
"I can't say enough about how great the trajectory of this company is," Cramer said. "I think you should own it, continue to own it."
2025-12-23 21:31
5 Stocks to Buy and 5 to Sell for 2026
Santa's Naughty and Nice list for stocks: Avoid expensive options on ORCL, LULU, PAYX, CIEN, and FDS. Premiums too high for profitable trades.
2025-12-12 04:48
电话会总结 ｜ Rubrik(RBRK)2026财年Q3业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Rubrik业绩会实录，以下是2026财年第三季度的业绩回顾摘要： ## 1. 财务业绩 **营收表现：** - 订阅收入：3.36亿美元，同比增长52% - 总收入：3.5亿美元，同比增长48% - 美洲地区收入：2.56亿美元，同比增长51% - 美洲以外地区收入：9400万美元，同比增长51% - 扣除材料权利影响后的标准化收入增长率约为36% **盈利能力：** - Non-GAAP毛利率：83%，较上年同期的79%有所提升 - 订阅ARR贡献利润率：过去12个月为正10%，较上年同期的负3%改善约1400个基点 **现金流：** - 自
2025-12-10 12:11
SailPoint beats Q3 estimates
SailPoint, Inc. press release (SAIL): Q3 Non-GAAP EPS of $0.08 beats by $0.02. Revenue of $282M(+20% Y/Y) beats by $11.47M. Total ARR was $1,040 million, an increase of 28% year-over-year. SaaS ARR wa...
2025-12-09 20:10
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
美股盘后 | Ares Management LP涨7.04%，Sailpoint科技涨2.67%
Ares Management LP涨7.04%；Sailpoint科技涨2.67%；英伟达涨2.40%
2025-12-09 07:12
